Average Co-Inventor Count = 2.12
ph-index = 31
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. The University of North Carolina at Chapel Hill (45 from 1,274 patents)
2. University of Pittsburgh (6 from 1,869 patents)
3. Other (4 from 832,912 patents)
4. Princeton University (4 from 1,091 patents)
5. Asklepios Biopharmaceutical, Inc. (4 from 11 patents)
6. University of Florida Research Foundation Inc (3 from 2,932 patents)
7. Bamboo Therapeutics, Inc. (3 from 3 patents)
8. Asklepios Biopharmaceuticals, Inc. (1 from 1 patent)
9. Cell Genesys, Inc. (78 patents)
66 patents:
1. 12319715 - Modified capsid proteins for enhanced delivery of parvovirus vectors
2. 12281335 - Methods and compositions for delivery of viral vectors across the blood-brain barrier
3. 12257321 - Optimized mini-dystrophin genes and expression cassettes and their use
4. 12201697 - AAV-IDUA vector for treatment of MPS I-associated blindness
5. 12049478 - Methods and compositions for dual glycan binding AAV vectors
6. 11939597 - Restrictive inverted terminal repeats for viral vectors
7. 11905533 - Methods and compositions for delivery of viral vectors across the blood-brain barrier
8. 11702676 - Rational polyploid adeno-associated virus vectors for the treatment of disease
9. 11639509 - Methods and compositions for dual glycan binding AAV2.5 vector
10. 11547765 - Optimized mini-dystrophin genes and expression cassettes and their use
11. 11542478 - Restrictive inverted terminal repeats for viral vectors
12. 11414678 - Modified soluble VEGF receptor-1 genes and vectors for gene therapy
13. 11124546 - Modified capsid proteins for enhanced delivery of parvovirus vectors
14. 11116850 - AAV-IDUA vector for treatment of MPS I-associated blindness
15. 11059862 - Methods and compositions for dual glycan binding AAV vectors